Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1016/s1473-3099(13)70318-9 | Antibiotic resistance—the need for global solutions |
| https://doi.org/10.1136/thx.2010.153643 | Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI) |
| https://doi.org/10.1111/j.1468-1331.2006.01537.x | A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS‐ES Task Force |
| https://doi.org/10.1111/ene.13539 | European Academy of Neurology and European Stroke Organization consensus statement and practical guidance for pre‐hospital management of stroke |
| https://doi.org/10.1016/j.ejca.2022.09.005 | Access and quality of biomarker testing for precision oncology in Europe |
| https://doi.org/10.1007/s43441-021-00282-z | Sustaining Meaningful Patient Engagement Across the Lifecycle of Medicines: A Roadmap for Action |
| https://doi.org/10.1016/j.atherosclerosis.2025.119218 | The Brussels International Declaration on Lipoprotein(a) Testing and Management |
| https://doi.org/10.1002/cpt.2462 | Use of Real‐World Data and Evidence in Drug Development of Medicinal Products Centrally Authorized in Europe in 2018–2019 |
| https://doi.org/10.1177/0023677219887998 | The European Federation of the Pharmaceutical Industry and Associations’ Research and Animal Welfare Group: Assessing and benchmarking ‘Culture of Care’ in the context of using animals for scientific purpose |
| https://doi.org/10.1515/cclm-2024-1022 | A vision to the future: value-based laboratory medicine |
| https://doi.org/10.1016/j.yrtph.2024.105683 | Endeavours made by trade associations, pharmaceutical companies and regulators in the replacement, reduction and refinement of animal experimentation in safety testing of pharmaceuticals |
| https://doi.org/10.1093/rheumatology/keaf445 | A screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC score |
| https://doi.org/10.1016/j.yrtph.2012.06.001 | The 3T3 neutral red uptake phototoxicity test: Practical experience and implications for phototoxicity testing – The report of an ECVAM–EFPIA workshop |
| https://doi.org/10.1111/anu.12194 | Growth, feed utilization and endocrine responses in Atlantic salmon (Salmo salar) fed diets added poultry by-product meal and blood meal in combination with poultry oil |
| https://doi.org/10.1016/j.ejps.2012.06.009 | Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT) |
| https://doi.org/10.1093/toxsci/kfq143 | Cross-Sector Review of Drivers and Available 3Rs Approaches for Acute Systemic Toxicity Testing |
| https://doi.org/10.1136/esmoopen-2019-000550 | Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries |
| https://doi.org/10.1016/j.chemosphere.2017.03.099 | Comprehensive strategy for pesticide residue analysis through the production cycle of gilthead sea bream and Atlantic salmon |
| https://doi.org/10.1016/j.yrtph.2018.08.006 | Finding synergies for 3Rs – Toxicokinetics and read-across: Report from an EPAA partners' Forum |
| https://doi.org/10.1016/s0140-6736(16)31425-8 | Increased momentum in antimicrobial resistance research |
| https://doi.org/10.1111/bcp.14279 | Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines |
| https://doi.org/10.1016/j.biologicals.2017.05.006 | Modern science for better quality control of medicinal products “Towards global harmonization of 3Rs in biologicals”: The report of an EPAA workshop |
| https://doi.org/10.1109/jbhi.2022.3198145 | Toward A Regulatory Pathway for the Use of in Silico Trials in the CE Marking of Medical Devices |
| https://doi.org/10.1136/ejhpharm-2022-003571 | EMA/HMA joint statement on the scientific rationale supporting interchangeability of biosimilar medicines in the EU |
| https://doi.org/10.1038/nrd3981 | Priorities for improving drug research, development and regulation |
| https://doi.org/10.1186/s13561-022-00379-7 | How can a joint European health technology assessment provide an ‘additional benefit’ over the current standard of national assessments? |
| https://doi.org/10.1016/j.yrtph.2015.07.007 | Knowledge sharing to facilitate regulatory decision-making in regard to alternatives to animal testing: Report of an EPAA workshop |
| https://doi.org/10.3389/fmed.2021.817663 | Repurposing of Medicines in the EU: Launch of a Pilot Framework |
| https://doi.org/10.1038/nm0312-341 | Public-private partnerships need honest brokering |
| https://doi.org/10.1016/j.jcpo.2023.100424 | The role of Real-World Data and evidence in oncology medicines approved in EU in 2018–2019 |
| https://doi.org/10.1177/2168479016666586 | Current Practices in Choosing Estimands and Sensitivity Analyses in Clinical Trials: Results of the ICH E9 Survey |
| https://doi.org/10.3389/fmed.2021.579822 | Medicine Shortages: From Assumption to Evidence to Action - A Proposal for Using the FMD Data Repositories for Shortages Monitoring |
| https://doi.org/10.1080/10408444.2021.2008867 | A broader view on deriving a reference dose for THC traces in foods |
| https://doi.org/10.1016/j.yrtph.2023.105339 | The use of recovery animals in nonclinical safety assessment studies with monoclonal antibodies: further 3Rs opportunities remain |
| https://doi.org/10.1016/j.foodcont.2016.07.041 | Multi-laboratory evaluation of a PCR method for detection of ruminant DNA in commercial processed animal proteins |
| https://doi.org/10.1016/j.eclinm.2023.102061 | Achieving consensus on the language of obesity: a modified Delphi study |
| https://doi.org/10.1038/nrd4026 | LifeTrain: towards a European framework for continuing professional development in biomedical sciences |
| https://doi.org/10.1017/s0266462317000174 | A NEW HEALTH TECHNOLOGY ASSESSMENT SYSTEM FOR JAPAN? SIMULATING THE POTENTIAL IMPACT ON THE PRICE OF SIMEPREVIR |
| https://doi.org/10.1186/s13561-022-00402-x | Shaping a research agenda to ensure a successful European health technology assessment: insights generated during the inaugural convention of the European Access Academy |
| https://doi.org/10.1186/s12913-021-06721-9 | Patients perspectives on drug shortages in six European hospital settings – a cross sectional study |
| https://doi.org/10.14573/altex.2503241 | EU roadmap for phasing out animal testing for chemical safety assessments: Recommendations from a multi-stakeholder roundtable |
| https://doi.org/10.1136/ejhpharm-2019-001911 | Medicines shortages |
| https://doi.org/10.1016/j.drudis.2023.103526 | Role of innovation in pharmaceutical regulation: A proposal for principles to evaluate EU General Pharmaceutical Legislation from the innovator perspective |
| https://doi.org/10.1136/ejhpharm-2022-003470 | Advanced therapy medicinal products |
| https://doi.org/10.1136/ejhpharm-2020-002628 | Position paper on pharmacy preparations and compounding |
| https://doi.org/10.1136/ejhpharm-2019-002004 | EAHP opinion on pharmaceuticals in the environment |
| https://doi.org/10.1136/ejhpharm-2023-003919 | Hospital pharmacy workforce |
| https://doi.org/10.1177/25151355241308305 | From setbacks to success: lessons from the journey of RSV vaccine development |
| https://doi.org/10.1038/d41573-025-00080-4 | Innovative Medicines Initiative public–private partnerships to enhance translational safety |
| https://doi.org/10.1016/j.yrtph.2025.106017 | Dietary administration of α-terpineol to Sprague-Dawley rats for 90 days |
| https://doi.org/10.1016/s0168-1605(03)00187-9 | EU assessment of enterococci as feed additives |
| https://doi.org/10.1016/j.chemosphere.2016.03.091 | Investigation of pharmaceuticals in processed animal by-products by liquid chromatography coupled to high-resolution mass spectrometry |
| https://doi.org/10.1016/j.jclepro.2019.03.179 | The ISO 14067 approach to open-loop recycling of paper products: Making it operational |
| https://doi.org/10.1007/s10603-007-9032-7 | Passengers, consumers, and travellers: The rise of passenger rights in EC transport law and its repercussions for Community consumer law and policy |
| https://doi.org/10.1111/j.1547-5069.2009.01307.x | A New Information Exchange System for Nursing Professionals to Enhance Patient Safety Across Europe |
| https://doi.org/10.1111/cts.13129 | How can real‐world evidence aid decision making during the life cycle of nonprescription medicines? |
| https://doi.org/10.1007/s43441-022-00383-3 | Regulatory Flexibilities and Guidances for Addressing the Challenges of COVID-19 in the EU: What Can We Learn from Company Experiences? |
| https://doi.org/10.1016/j.yrtph.2018.08.002 | One science-driven approach for the regulatory implementation of alternative methods: A multi-sector perspective |
| https://doi.org/10.1136/ejhpharm-2020-002559 | Pharmacy preparations and compounding |
| https://doi.org/10.1002/1878-0261.13078 | The Porto European Cancer Research Summit 2021 |
| https://doi.org/10.1016/j.biologicals.2022.06.003 | Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps. A workshop Report |
| https://doi.org/10.1002/chem.201501364 | Guest Editorial: The Professional Status of European Chemists and Chemical Engineers |
| https://doi.org/10.2131/jts.33.277 | Safety assessment of biopharmaceuticals: Japanese perspective on ICH S6 guideline maintenance |
| https://doi.org/10.3390/su14159607 | Skill Needs for Sustainable Agri-Food and Forestry Sectors (I): Assessment through European and National Focus Groups |
| https://doi.org/10.1111/ejn.13236 | Consensus Statement on European Brain Research: the need to expand brain research in Europe – 2015 |
| https://doi.org/10.1016/s2213-8587(16)30003-1 | Health-care access of transgender people: a medical student approach |
| https://doi.org/10.1136/ejhpharm-2021-003168 | Show how you keep antibiotics working during this year’s EAAD |
| https://doi.org/10.1111/anu.12121 | Residue levels of enrofloxacin and ciprofloxacin in processed animal by-products used in Atlantic salmon feeds and their long-term carry-over to the edible part of the fish |
| https://doi.org/10.1177/2168479015618697 | Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to Implementation |
| Making progress and gaining momentum in global 3Rs efforts: how the European pharmaceutical industry is contributing. | |
| https://doi.org/10.1016/j.drup.2011.01.005 | The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance |
| https://doi.org/10.3978/j.issn.2304-3865.2014.05.07 | Medicine adaptive pathways to patients (MAPPs): using regulatory innovation to defeat Eroom's law. |
| https://doi.org/10.3390/pharmacy3030101 | A European Competence Framework for Industrial Pharmacy Practice in Biotechnology |
| https://doi.org/10.1016/s1470-2045(11)70370-9 | Drivers of the cost of cancer care |
| https://doi.org/10.1038/nrd4114 | Appropriate evidence for adaptive marketing authorization |
| https://doi.org/10.7175/fe.v13i2.270 | Pricing and reimbursement of innovative pharmaceuticals in France and the new healthcare reform |
| https://doi.org/10.1136/ejhpharm-2019-001910 | Position paper on an ageing society |
| https://doi.org/10.1203/00006450-198408000-00005 | Abnormal Fatty Acid Turnover in the Phospholipids of the Red Blood Cell Membranes of Cystic Fibrosis Patients (in Vitro Study) |
| https://doi.org/10.2515/therapie:2006059 | Public-Private Partnership Models in France and in Europe |
| https://doi.org/10.1177/026119290803600312 | Optimisation of the Post-validation Process |
| https://doi.org/10.1136/ejhpharm-2018-001821 | Biosimilar medicines |
| https://doi.org/10.1016/j.hlpt.2014.10.007 | European data-driven economy: A lighthouse initiative on Personalised Medicine |
| https://doi.org/10.1027/1016-9040/a000085 | The History and Organization of the European Federation of Psychologists’ Associations (EFPA) |
| https://doi.org/10.1017/cbo9780511976087.013 | EUROPEAN NEW SAFE AND INNOVATIVE MEDICINES INITIATIVES: HISTORY AND PROGRESS (THROUGH DECEMBER 2009) |
| https://doi.org/10.1136/ejhpharm-2022-003413 | European health data space proposal launched |
| https://doi.org/10.1016/s0140-6736(07)60399-7 | Direct-to-consumer drug information in Europe |
| https://doi.org/10.1038/nrd.2018.72 | Impact of the Innovative Medicines Initiative on vaccine development |
| https://doi.org/10.1136/ejhpharm-2019-002005 | New interagency AMR report calls for urgent action |
| https://doi.org/10.1136/bmjopen-2020-048338 | Management of asthma in childhood: study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank |
| https://doi.org/10.1002/cpt.3428 | The Rare Disease Moonshot: Paradigms Shift, Translational Medicine, and Regulatory Science for the World's Rarest Conditions |
| https://doi.org/10.1136/ejhpharm-2019-002167 | What will the new European Commission deliver in the field of health? |
| https://doi.org/10.1136/ejhpharm-2023-003920 | Infectious diseases and antimicrobial resistance |
| https://doi.org/10.1007/s43441-025-00824-9 | Reliance into Action |
| https://doi.org/10.1007/978-3-031-20298-8_3 | Availability of Medicines |
| https://doi.org/10.1136/ejhpharm-2019-001924 | Position paper on patient safety |
| https://doi.org/10.1007/s10147-022-02149-1 | Guidance on the need for contraception related to use of pharmaceuticals: the Japan Agency for Medical Research and Development Study Group for providing information on the proper use of pharmaceuticals in patients with reproductive potential |
| https://doi.org/10.1002/ejp.2015 | Why do we need to implement the |
| https://doi.org/10.3389/fdata.2022.945739 | A concentric circles view of health data relations facilitates understanding of sociotechnical challenges for learning health systems and the role of federated data networks |
| https://doi.org/10.1093/eurpub/ckac129.328 | Accounting for vaccines specificities in the Joint Clinical Assessment (JCA): a proposal for guiding principles |
| https://doi.org/10.1136/ejhpharm-2023-003862 | Hospital pharmacists’ first impressions on the revision of the General Pharmaceutical Legislation |